Cargando…

Can the Market Recognize the Value of the Corporate Governance Mechanism of Chinese Listed Companies?—Empirical Evidence From COVID-19

This paper studies whether the market can recognize the value of corporate governance mechanisms (ownership structure, board structure, and managerial incentives) of Chinese listed companies. We find that when companies are faced with “black swan” events, such as COVID-19, non-state-owned enterprise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianwei, Ma, Yunbiao, Shi, Beibei, Yang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826234/ https://www.ncbi.nlm.nih.gov/pubmed/35155358 http://dx.doi.org/10.3389/fpubh.2021.812253

Ejemplares similares

Corporate financialization, financing constraints, and innovation efficiency—Empirical evidence based on listed Chinese pharmaceutical companies
por: Zhu, Jialin, et al.
Publicado: (2023)

An Empirical Study on the Equity Performance of China's Health Insurance Companies During the COVID-19 Pandemic—Based on Cases of Dominant Listed Companies
por: Ye, Rendao, et al.
Publicado: (2021)

COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility
por: Sun, Yunpeng, et al.
Publicado: (2021)

An empirical study on the asset-light operation and corporate performance of China's tourism listed companies
por: Liang, Shi, et al.
Publicado: (2023)

CEO turnover and corporate innovation: What can we learn from Chinese listed companies
por: Sun, Shujun, et al.
Publicado: (2022)

Initiative for China to establish a dual model of mixed corporate governance on bankruptcy reorganization: An empirical analysis based on 93 listed companies()
por: Yuxia, Song, et al.
Publicado: (2022)

Majority of Fortune 500 Companies in 2018 Did Not Recognize Risk of Epidemics Such as COVID-19
por: MacDonald, Pia D. M., et al.
Publicado: (2021)

Information disclosure, practical actions and dynamics of employees' health and safety issues in Chinese family businesses—Evidence based on Chinese a-share listed companies
por: Guo, Yi, et al.
Publicado: (2022)

Do environmental, social, and governance scores improve green innovation? Empirical evidence from Chinese-listed companies
por: Zhang, Chunlian, et al.
Publicado: (2023)

Corporate social responsibility, financing constraints, and corporate carbon intensity: new evidence from listed Chinese companies
por: Chen, Pengyu
Publicado: (2023)

Equity incentive contract characteristics and company operational performance—An empirical study of Chinese listed companies
por: Qiao, Mingzhe, et al.
Publicado: (2023)

Central environmental inspection and corporate environmental investment: evidence from Chinese listed companies
por: Wang, Junshui, et al.
Publicado: (2022)

Assessing the competitiveness of listed Chinese high-growth companies in the STAR market
por: Zhang, Wei, et al.
Publicado: (2023)

Value chain carbon footprints of Chinese listed companies
por: Zhang, Zengkai, et al.
Publicado: (2023)

Impact of quantitative safety targets on road fatality reduction: an empirical support toward governance plan
por: Cui, Haizhou, et al.
Publicado: (2023)

Can fund shareholding inhibit insufficient R&D input?——Empirical evidence from Chinese listed companies
por: Li, Xiao, et al.
Publicado: (2021)

Does Overseas Investment Raise Corporate Environmental Protection? Evidence from Chinese A-List Companies
por: Wang, Quan-Jing, et al.
Publicado: (2022)

Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms
por: Zhang, Ci, et al.
Publicado: (2021)

The companies we keep: corporate governance for a democratic society
por: Hutchinson, Allan C
Publicado: (2005)

The impact of industry-university-research projects on biopharmaceutical companies’ innovation performance: moderating roles of government subsidies for innovation
por: Xia, Yuntian, et al.
Publicado: (2023)

The Corporate Purpose of Spanish Listed Companies: Neurocommunication Research Applied to Organizational Intangibles
por: Mañas-Viniegra, Luis, et al.
Publicado: (2020)

Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market
por: Tian, Jing, et al.
Publicado: (2022)

An empirical study of the impact of generic drug competition on drug market prices in China
por: Yina, Chen, et al.
Publicado: (2023)

Government subsidies and innovation in new energy vehicle companies: An empirical study of new energy vehicle listed companies based on Shanghai and Shenzhen A-shares
por: Sun, Jianguo, et al.
Publicado: (2023)

The Impact of Government Official Assessment on Ecological Poverty Alleviation: Evidence from Chinese Listed Companies
por: Huang, Yujing
Publicado: (2022)

The impact of COVID-19 on cultural industries: An empirical research based on stock market returns
por: Zhang, Rong, et al.
Publicado: (2022)

The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies—An Empirical Study Based on the Difference-in-Differences Model
por: Wei, Yanyi, et al.
Publicado: (2022)

The impact of perceived value and affection on Chinese residents' continuous use intention of mobile health science information: An empirical study
por: Tian, Kun, et al.
Publicado: (2023)

The Economic Effects of Direct and Indirect Employee Involvement: Evidence From Corporate Social Responsibility Reports of Chinese Listed Companies
por: Jiang, Yongzhong, et al.
Publicado: (2021)

Does digital finance promote corporate social responsibility of pollution-intensive industry? Evidence from Chinese listed companies
por: Xin, Daleng, et al.
Publicado: (2022)

Path analysis and empirical test of medical service enhancement for common prosperity under government participation
por: Chen, Baoqi, et al.
Publicado: (2023)

Air Pollution and Corporate Green Financial Constraints: Evidence from China’s Listed Companies
por: Shen, Yi, et al.
Publicado: (2022)

Epidemic Prevention During Work Resumption: A Case Study of One Chinese Company's Experience
por: Zhang, Quan, et al.
Publicado: (2021)

Will executive equity incentives affect investor relations management: Empirical evidence from Chinese listed companies
por: Shi, Xiaofei, et al.
Publicado: (2022)

Corporate governance and firm value: econometric modellling and analysis of emerging and developed financial markets
por: Rashid, Kashif, et al.
Publicado: (2008)

Analysis of the Impact of Supply Chain Relationship Strategy on Corporate Cash Dividend Policy Based on Chinese Data
por: Yang, Xingquan, et al.
Publicado: (2022)

Promoting and inhibiting: Corporate charitable donations and innovation investment under different motivation orientations——Evidence from Chinese listed companies
por: Wang, Hongpeng, et al.
Publicado: (2022)

Impact of Corporate Reputation on Brand Differentiation: An Empirical Study from Iranian Pharmaceutical Companies
por: vahabzadeh, Afshin, et al.
Publicado: (2017)

Does corporate governance affect financial analysts’ stock recommendations, target prices accuracy and earnings forecast characteristics? An empirical investigation of US companies
por: Bouteska, Ahmed, et al.
Publicado: (2022)

Who monitors the monitors? An examination of listed companies in an emerging market context
por: Janse van Vuuren, Michael R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j9vaeos6oehsk1mtg3deecjf42